middle.news
Biotron Advances Hepatitis B Drug After Successful Animal Safety Trial
12:11pm on Tuesday 24th of June, 2025 AEST
•
Biotechnology
Read Story
Biotron Advances Hepatitis B Drug After Successful Animal Safety Trial
12:11pm on Tuesday 24th of June, 2025 AEST
Key Points
First stage animal safety study for HBV drug completed successfully
No toxicity observed at various dosages in mice
Next phase to test antiviral efficacy in two HBV mouse models
Research conducted at SCRIPPS Research Institute, USA
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Biotron (ASX:BIT)
OPEN ARTICLE